PET-positive lymphadenopathy in CLL-Not always Richter transformation
Authors: Naveen Pemmaraju, Preetesh Jain, L. Jeffrey Medeiros, Jeffrey L. Jorgenson, Nitin Jain, Jason Willis, Dimitrios P. Kontoyiannis, Zeev Estrov, William G. Wierda
Journal: American Journal of Hematology (2016)

Image 1. Whole body PET-CT and histopathological features of a lymph node biopsy specimen involved by chronic lymphocytic leukemia (CLL) and necrosis attributable to herpes simplex virus (HSV) infection. A: Enlarged, metabolically active, likely centrally necrotic, right greater and left inguinal lymph nodes. Prominent 4 cm × 5 cm right inguinal lymph node with SUV of 9.85 is seen. B: A core needle biopsy specimen showing replacement of lymph node by viable CLL (left of field) and necrosis (right of field). C: High magnification of CLL showing small lymphocytes and increased intermediate-size to large cells (arrows) consistent with prolymphocytes and paraimmunoblasts. D: High magnification of the necrosis showing scattered necrotic large cells with intranuclear inclusions typical of the Cowdry type A HSV inclusions (arrows). E: Immunohistochemistry for HSV (types I and II) is positive in the large cells with viral inclusions (arrows). A 70-year-old man with chronic lymphocytic leukemia (CLL) presented in June of 2016 with a one-month history of gradual onset, intermittent non-neutropenic fevers up to 103.4°F and night sweats, which did not improve despite treatment with broad spectrum antibiotics. Multiple blood, urine, and sputum cultures remained negative. Additionally, the patient had new onset, enlarged inguinal lymph nodes that were associated with a non-pruritic, non-tender rash on his bilateral upper and lower extremities, intermittent migratory arm swelling, and approximately 10 pounds of weight loss. The patient was diagnosed with CLL in 2007, with unmutated IGHV and trisomy 12. He was treated first-line with idelalisib plus rituximab on a clinical trial, but was discontinued 5 years later due to intolerance. He had stable disease subsequent to discontinuation of treatment and did not receive subsequent systemic treatment for CLL. The patient developed warm antibody autoimmune hemolytic anemia in June, 2013 and was treated with various immunosuppressive regimens, undergoing splenectomy in March, 2014. Physical examination showed a generalized erythematous, maculopapular skin rash and bulky inguinal lymphadenopathy. His initial laboratory tests demonstrated: WBC 48.1 K/uL, HGB 11.8 g/dL, PLT 371 K/uL with normal LDH and liver and renal function tests. Bone marrow (BM) examination showed CLL with trisomy 12 and NOTCH1 and BIRC3 mutations. Infectious work up was negative for all pathogens by standard testing as well as cultures of blood, urine, and sputum. Quantitative PCR for HSV 1 and 2 was negative. The patient was treated empirically with broad spectrum antimicrobial agents and one dose of intravenous immunoglobulin (IVIG) for suspected autoimmune hemolysis (Serum IgG was normal). Positron emission tomography-CT scan (PET-CT) showed generalized lymphadenopathy with F-18 fluorodeoxyglucose (FDG) uptake highest in inguinal lymph nodes, with standardized uptake value (SUV) of 9.8 (Image 1 A). Core biopsy of an inguinal lymph node was performed to assess for Richter transformation (RT). Pathology evaluation revealed a diffuse infiltrate of intermediate-size to large cells with prolymphocytic and paraimmunoblastic morphology and interspersed, well-demarcated areas of suppurative necrosis (Image 1B,C). Scattered degenerated large cells with nuclear inclusions of Cowdry type A were also observed. Immunohistochemistry (IHC) showed many lymphocytes positive for CD5 and PAX5 consistent with CLL with an increased proliferation (Ki-67) rate of 30–50%. The antibody specific for herpes simplex virus (HSV, subtypes I and II) highlighted many cells within the necrotic areas including the cells with nuclear inclusions (Image 1D,E). Based on these findings, the diagnosis of HSV lymphadenitis was rendered. The patient responded well to treatment with intravenous acyclovir, and was discharged in stable condition upon successful transition to valacyclovir. Infrequently we have observed other CLL patients with suspected RT, based on PET-scan, shown by biopsy to have HSV lymphadenitis (unpublished data). Progressive lymphadenopathy with high SUV on PET scan in patients with CLL can indicate disease transformation 1. However, histopathological features with biopsy/tissue analysis must be performed before finalizing the diagnosis of RT to exclude other etiologies. HSV lymphadenitis is rarely reported in patients with CLL and generally responds well to antiviral agents 2, 3. Furthermore, CLL lymph nodes exhibiting increased prolymphocytes or paraimmunoblasts may represent antigen activation or re-activation of latent viruses, such as HSV. In conclusion, increased prolymphocytes or paraimmunoblasts in lymph nodes from patients with CLL with PET-positive disease may not always represent accelerated CLL 4 or RT; consideration of infectious etiologies as mimickers of RT 5, as in this case, is warranted. NP, PJ, LJM, JLJ, NJ, JW, DPK, ZE, and WW gathered the data and evaluated the clinical presentation and pathology, and all authors have reviewed and approved the manuscript and do not have any disclosures.